{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:08:15Z","timestamp":1793066895531,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Andreas Mentzelopoulos Foundation"},{"name":"Catholic University of C\u00f3rdoba"},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP- 2021-2023"],"award-info":[{"award-number":["PIP- 2021-2023"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-1381"],"award-info":[{"award-number":["PICT 2017-1381"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chemotherapy is a powerful means of cancer treatment but its efficacy is compromised by the emergence of multidrug resistance\u00a0(MDR), mainly linked to the efflux transporter ABCB1\/P-glycoprotein (P-gp). Based on the chemical structure of betulin, identified in our previous work as an effective modulator of the P-gp function, a series of analogs were designed, synthesized and evaluated as a source of novel inhibitors. Compounds\n                    <jats:bold>6g<\/jats:bold>\n                    and\n                    <jats:bold>6i<\/jats:bold>\n                    inhibited rhodamine 123 efflux in the P-gp overexpressed leukemia cells, K562\/Dox, at concentrations of 0.19\u00a0\u00b5M and 0.39\u00a0\u00b5M, respectively, and increased the intracellular accumulation of doxorubicin at the submicromolar concentration of 0.098\u00a0\u00b5M. Compounds\n                    <jats:bold>6g<\/jats:bold>\n                    and\n                    <jats:bold>6i<\/jats:bold>\n                    were able to restore the sensitivity of K562\/Dox to Dox at 0.024\u00a0\u00b5M and 0.19\u00a0\u00b5M, respectively. Structure\u2013activity relationship analysis and molecular modeling revealed important information about the structural features conferring activity. All the active compounds fitted in a specific region involving mainly transmembrane helices (TMH) 4\u20136 from one homologous half and TMH 7 and 12 from the other, also showing close contacts with TMH 6 and 12. Compounds that bound preferentially to another region were inactive, regardless of their free energy of binding. It should be noted that compounds\n                    <jats:bold>6g<\/jats:bold>\n                    and\n                    <jats:bold>6i<\/jats:bold>\n                    were devoid of toxic effects against peripheral blood mononuclear normal cells and erythrocytes. The data obtained indicates that both compounds might be proposed as scaffolds for obtaining promising P-gp inhibitors for overcoming MDR.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-49939-9","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T06:02:21Z","timestamp":1704175341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein"],"prefix":"10.1038","volume":"14","author":[{"given":"Jer\u00f3nimo","family":"Laiolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafni G.","family":"Graikioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia L.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana B.","family":"Joray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia I.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Mariano A.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos M.","family":"Athanassopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Carpinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"49939_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/PPO.0000000000000416","volume":"25","author":"TJ Kipps","year":"2019","unstructured":"Kipps, T. J. & Choi, M. Y. Targeted therapy in chronic lymphocytic leukemia. Cancer J. (Sudbury Mass.) 25, 378 (2019).","journal-title":"Cancer J. (Sudbury Mass.)"},{"key":"49939_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-18722-4","volume-title":"Principles of Cancer Treatment and Anticancer Drug Development","author":"W Link","year":"2019","unstructured":"Link, W. Principles of Cancer Treatment and Anticancer Drug Development (Springer, 2019)."},{"key":"49939_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee, Y. T., Tan, Y. J. & Oon, C. E. Molecular targeted therapy: Treating cancer with specificity. Eur. J. Pharmacol. 834, 188\u2013196 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"49939_CR4","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.ejmech.2022.114542","volume":"239","author":"K Engle","year":"2022","unstructured":"Engle, K. & Kumar, G. Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. Eur. J. Med. Chem. 239, 114542 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR5","doi-asserted-by":"publisher","first-page":"e1291","DOI":"10.1002\/cnr2.1291","volume":"5","author":"FU Vaidya","year":"2020","unstructured":"Vaidya, F. U. et al. Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Rep. 5, e1291 (2020).","journal-title":"Cancer Rep."},{"key":"49939_CR6","doi-asserted-by":"publisher","first-page":"84559","DOI":"10.18632\/oncotarget.19187","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang, J., Seebacher, N., Shi, H., Kan, Q. & Duan, Z. Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget 8, 84559\u201384571 (2017).","journal-title":"Oncotarget"},{"key":"49939_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/molecules23010119","volume":"23","author":"RC Maia","year":"2018","unstructured":"Maia, R. C., Vasconcelos, F. C., Souza, P. S. & Rumjanek, V. M. Towards comprehension of the ABCB1\/P-glycoprotein role in chronic myeloid leukemia. Molecules 23, 119 (2018).","journal-title":"Molecules"},{"key":"49939_CR8","doi-asserted-by":"publisher","first-page":"103281","DOI":"10.1016\/j.critrevonc.2021.103281","volume":"160","author":"FC Vasconcelos","year":"2021","unstructured":"Vasconcelos, F. C., de Souza, P. S., Hancio, T., de Faria, F. C. C. & Maia, R. C. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting. Crit. Rev. Oncol. Hematol. 160, 103281 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"49939_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl, S. et al. The biology of chronic myeloid Leukemia. N. Engl. J. Med. 341, 164\u2013172 (1999).","journal-title":"N. Engl. J. Med."},{"key":"49939_CR10","doi-asserted-by":"publisher","first-page":"106641","DOI":"10.1016\/j.leukres.2021.106641","volume":"109","author":"SK Gupta","year":"2021","unstructured":"Gupta, S. K., Singh, P., Chhabra, R. & Verma, M. Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line. Leuk. Res. 109, 106641 (2021).","journal-title":"Leuk. Res."},{"key":"49939_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41375-020-0842-9","volume":"34","author":"A Hochhaus","year":"2020","unstructured":"Hochhaus, A. et al. Expert opinion\u2014Management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors. Leukemia 34, 1495\u20131502 (2020).","journal-title":"Leukemia"},{"key":"49939_CR12","first-page":"1910","volume":"39","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK\/STAT3 signaling pathway in human chronic myelogenous leukemia K562\/ADM cells. Oncol. Rep. 39, 1910\u20131918 (2018).","journal-title":"Oncol. Rep."},{"key":"49939_CR13","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1080\/10428194.2020.1811269","volume":"61","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562\/ADM cells. Leuk. Lymphoma 61, 3451\u20133459 (2020).","journal-title":"Leuk. Lymphoma"},{"key":"49939_CR14","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2020.448","author":"SK Gupta","year":"2020","unstructured":"Gupta, S. K., Singh, P., Ali, V. & Verma, M. Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncol. Rev. https:\/\/doi.org\/10.4081\/oncol.2020.448 (2020).","journal-title":"Oncol. Rev."},{"key":"49939_CR15","doi-asserted-by":"publisher","first-page":"e23374","DOI":"10.1002\/jcla.23374","volume":"34","author":"M Ammar","year":"2020","unstructured":"Ammar, M. et al. Overexpression of P-glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients. J. Clin. Lab. Anal. 34, e23374 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"49939_CR16","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.drup.2022.100905","volume":"66","author":"J Fan","year":"2023","unstructured":"Fan, J., To, K. K. W., Chen, Z.-S. & Fu, L. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance. Drug Resist. Updat. 66, 100905 (2023).","journal-title":"Drug Resist. Updat."},{"key":"49939_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jchromb.2018.03.007","volume":"1084","author":"Z Qiu","year":"2018","unstructured":"Qiu, Z. et al. Development and application of a UPLC\u2013MS\/MS method for P-glycoprotein quantification in human tumor cells. J. Chromatogr. B 1084, 14\u201322 (2018).","journal-title":"J. Chromatogr. B"},{"key":"49939_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jebm.12434","volume":"14","author":"JQ Wang","year":"2021","unstructured":"Wang, J. Q. et al. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates. J. Evid.-Based Med. 14, 232\u2013256 (2021).","journal-title":"J. Evid.-Based Med."},{"key":"49939_CR19","doi-asserted-by":"publisher","first-page":"13089","DOI":"10.3390\/ijms241713089","volume":"24","author":"P Szatm\u00e1ri","year":"2023","unstructured":"Szatm\u00e1ri, P. & Ducza, E. Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy. Int. J. Mol. Sci. 24, 13089 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"49939_CR20","doi-asserted-by":"publisher","first-page":"e0204693","DOI":"10.1371\/journal.pone.0204693","volume":"13","author":"A Sajid","year":"2018","unstructured":"Sajid, A., Lusvarghi, S., Chufan, E. E. & Ambudkar, S. V. Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1). PLoS ONE 13, e0204693 (2018).","journal-title":"PLoS ONE"},{"key":"49939_CR21","doi-asserted-by":"publisher","first-page":"108675","DOI":"10.1016\/j.abb.2020.108675","volume":"696","author":"L Wang","year":"2020","unstructured":"Wang, L. & Sun, Y. Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein. Arch. Biochem. Biophys. 696, 108675 (2020).","journal-title":"Arch. Biochem. Biophys."},{"key":"49939_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1021\/acs.biochem.2c00056","volume":"61","author":"AF Clouser","year":"2022","unstructured":"Clouser, A. F. & Atkins, W. M. Long range communication between the drug-binding sites and nucleotide binding domains of the efflux transporter ABCB1. Biochemistry (Mosc) 61, 730\u2013740 (2022).","journal-title":"Biochemistry (Mosc)"},{"key":"49939_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/med.21739","volume":"41","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Med. Res. Rev. 41, 525\u2013555 (2021).","journal-title":"Med. Res. Rev."},{"key":"49939_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. & Gottesman, M. M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5, 219\u2013234 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"49939_CR25","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.2174\/092986712800167392","volume":"19","author":"A Palmeira","year":"2012","unstructured":"Palmeira, A., Sousa, E., Vasconcelos, H. & Pinto, M. Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr. Med. Chem. 19, 1946\u20132025 (2012).","journal-title":"Curr. Med. Chem."},{"key":"49939_CR26","doi-asserted-by":"publisher","first-page":"14895","DOI":"10.1021\/acs.jmedchem.1c01452","volume":"64","author":"S Yuan","year":"2021","unstructured":"Yuan, S. et al. Discovery of new 4-indolyl quinazoline derivatives as highly potent and orally bioavailable P-glycoprotein inhibitors. J. Med. Chem. 64, 14895\u201314911 (2021).","journal-title":"J. Med. Chem."},{"key":"49939_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","volume":"52","author":"EK Davison","year":"2019","unstructured":"Davison, E. K. & Brimble, M. A. Natural product derived privileged scaffolds in drug discovery. Curr. Opin. Chem. Biol. 52, 1\u20138 (2019).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"49939_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.tibs.2020.03.004","volume":"45","author":"G Di Nardo","year":"2020","unstructured":"Di Nardo, G. & Gilardi, G. Natural compounds as pharmaceuticals: the key role of cytochromes P450 reactivity. Trends Biochem. Sci. 45, 511\u2013525 (2020).","journal-title":"Trends Biochem. Sci."},{"key":"49939_CR29","doi-asserted-by":"publisher","first-page":"112985","DOI":"10.1016\/j.ejmech.2020.112985","volume":"210","author":"DSP Cardoso","year":"2020","unstructured":"Cardoso, D. S. P. et al. Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells. Eur. J. Med. Chem. 210, 112985 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR30","doi-asserted-by":"publisher","first-page":"114207","DOI":"10.1016\/j.ejmech.2022.114207","volume":"232","author":"W Huang","year":"2022","unstructured":"Huang, W. et al. Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles. Eur. J. Med. Chem. 232, 114207 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00205","author":"ML Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez, M. L. et al. Mechanism underlying the reversal of drug resistance in P-glycoprotein-expressing leukemia cells by pinoresinol and the study of a derivative. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00205 (2017).","journal-title":"Front. Pharmacol."},{"key":"49939_CR32","doi-asserted-by":"publisher","first-page":"111922","DOI":"10.1016\/j.fct.2020.111922","volume":"147","author":"J Laiolo","year":"2021","unstructured":"Laiolo, J. et al. Plant extracts and betulin from Ligaria cuneifolia inhibit P-glycoprotein function in leukemia cells. Food Chem. Toxicol. 147, 111922 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"49939_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-96226-6","volume":"11","author":"J Laiolo","year":"2021","unstructured":"Laiolo, J. et al. Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp. Sci. Rep. 11, 1\u201318 (2021).","journal-title":"Sci. Rep."},{"key":"49939_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bioorg.2019.01.039","volume":"86","author":"Q Qiu","year":"2019","unstructured":"Qiu, Q. et al. Design, synthesis and biological evaluation of N-(4-(2-(6, 7-dimethoxy-3, 4-dihydroisoquinolin-2 (1H)-yl) ethyl) phenyl)-4-oxo-3, 4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance. Bioorg. Chem. 86, 166\u2013175 (2019).","journal-title":"Bioorg. Chem."},{"key":"49939_CR35","doi-asserted-by":"publisher","first-page":"115092","DOI":"10.1016\/j.ejmech.2023.115092","volume":"248","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7\/ADR cell. Eur. J. Med. Chem. 248, 115092 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR36","doi-asserted-by":"publisher","first-page":"113336","DOI":"10.1016\/j.ejmech.2021.113336","volume":"216","author":"Y-S Li","year":"2021","unstructured":"Li, Y.-S. et al. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7\/ADR cell. Eur. J. Med. Chem. 216, 113336 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejmech.2014.06.016","volume":"83","author":"N Zhang","year":"2014","unstructured":"Zhang, N. et al. 4, 5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells. Eur. J. Med. Chem. 83, 74\u201383 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR38","doi-asserted-by":"publisher","first-page":"113795","DOI":"10.1016\/j.ejmech.2021.113795","volume":"226","author":"IL Wong","year":"2021","unstructured":"Wong, I. L. et al. Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers. Eur. J. Med. Chem. 226, 113795 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejmech.2012.05.026","volume":"54","author":"J Yuan","year":"2012","unstructured":"Yuan, J. et al. Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells. Eur. J. Med. Chem. 54, 413\u2013422 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR40","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1021\/jm501371s","volume":"58","author":"AK Ghosh","year":"2015","unstructured":"Ghosh, A. K. & Brindisi, M. Organic carbamates in drug design and medicinal chemistry. J. Med. Chem. 58, 2895\u20132940 (2015).","journal-title":"J. Med. Chem."},{"key":"49939_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1472-6882-14-340","volume":"14","author":"V Kuete","year":"2014","unstructured":"Kuete, V. et al. Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern. Med. 14, 340 (2014).","journal-title":"BMC Complement Altern. Med."},{"key":"49939_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejmech.2018.01.092","volume":"147","author":"S Dei","year":"2018","unstructured":"Dei, S. et al. Design and synthesis of new potent N, N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents. Eur. J. Med. Chem. 147, 7\u201320 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"49939_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-83845-2","volume":"11","author":"PC Lyon","year":"2021","unstructured":"Lyon, P. C. et al. Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometry. Sci. Rep. 11, 1\u201319 (2021).","journal-title":"Sci. Rep."},{"key":"49939_CR44","first-page":"271","volume":"2","author":"JM Delou","year":"2009","unstructured":"Delou, J. M., Capella, M. A. M. & Gattass, C. R. Betulinic acid does not modulate the activity of P-gp\/ABCB1 or MRP1\/ABCC1 in a non-tumoral renal cell line: Possible utility in multidrug resistance cancer chemotherapy. Mol. Med. Rep. 2, 271\u2013275 (2009).","journal-title":"Mol. Med. Rep."},{"key":"49939_CR45","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1021\/acs.jcim.9b00429","volume":"59","author":"L Wang","year":"2019","unstructured":"Wang, L., Zhang, L., Liu, F. & Sun, Y. Molecular energetics of doxorubicin pumping by human P-glycoprotein. J. Chem. Inf. Model. 59, 3889\u20133898 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"49939_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/molecules22060871","volume":"22","author":"S Dewanjee","year":"2017","unstructured":"Dewanjee, S. et al. Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules 22, 871 (2017).","journal-title":"Molecules"},{"key":"49939_CR47","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.fct.2006.07.003","volume":"44","author":"N Yoshida","year":"2006","unstructured":"Yoshida, N., Koizumi, M., Adachi, I. & Kawakami, J. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Food Chem. Toxicol. 44, 2033\u20132039 (2006).","journal-title":"Food Chem. Toxicol."},{"key":"49939_CR48","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/acs.jnatprod.8b00326","volume":"81","author":"RJ Ferreira","year":"2018","unstructured":"Ferreira, R. J. et al. Terpenoids from Euphorbia pedroi as multidrug-resistance reversers. J. Nat. Prod. 81, 2032\u20132040 (2018).","journal-title":"J. Nat. Prod."},{"key":"49939_CR49","doi-asserted-by":"publisher","first-page":"639487","DOI":"10.3389\/fbioe.2021.639487","volume":"9","author":"X Song","year":"2021","unstructured":"Song, X. et al. Aptamer functionalized upconversion nanotheranostic agent with nuclear targeting as the highly localized drug-delivery system of doxorubicin. Frontiers in Bioeng. Biotechnol. 9, 639487 (2021).","journal-title":"Frontiers in Bioeng. Biotechnol."},{"key":"49939_CR50","doi-asserted-by":"publisher","first-page":"119320","DOI":"10.1016\/j.bbamcr.2022.119320","volume":"1869","author":"R Kitzinger","year":"2022","unstructured":"Kitzinger, R., Fritz, G. & Henninger, C. Nuclear RAC1 is a modulator of the doxorubicin-induced DNA damage response. Biochim. et Biophys. Acta (BBA) Mol. Cell Res. 1869, 119320 (2022).","journal-title":"Biochim. et Biophys. Acta (BBA) Mol. Cell Res."},{"key":"49939_CR51","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aav7102","volume":"363","author":"A Alam","year":"2019","unstructured":"Alam, A., Kowal, J., Broude, E., Roninson, I. & Locher, K. P. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science 363, 753 (2019).","journal-title":"Science"},{"key":"49939_CR52","doi-asserted-by":"publisher","first-page":"26245","DOI":"10.1073\/pnas.2010264117","volume":"117","author":"K Nosol","year":"2020","unstructured":"Nosol, K. et al. Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc. Natl. Acad. Sci. 117, 26245\u201326253 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"49939_CR53","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.bioconjchem.1c00137","volume":"32","author":"N Pediconi","year":"2021","unstructured":"Pediconi, N. et al. Design and synthesis of piperazine-based compounds conjugated to humanized ferritin as delivery system of siRNA in cancer cells. Bioconj. Chem. 32, 1105\u20131116 (2021).","journal-title":"Bioconj. Chem."},{"key":"49939_CR54","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.leukres.2014.06.001","volume":"38","author":"MAM Moreira","year":"2014","unstructured":"Moreira, M. A. M. et al. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line. Leuk. Res. 38, 983\u2013987 (2014).","journal-title":"Leuk. Res."},{"key":"49939_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 65, 55 (1983).","journal-title":"J. Immunol. Methods"},{"key":"49939_CR56","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/acs.jnatprod.0c00115","volume":"83","author":"MF Garc\u00eda Manzano","year":"2020","unstructured":"Garc\u00eda Manzano, M. F., Joray, M. B., Laiolo, J., Palacios, S. M. & Carpinella, M. C. Cytotoxic activity of germacrane-type sesquiterpene lactones from Dimerostemma aspilioides. J. Nat. Prod. 83, 1909\u20131918 (2020).","journal-title":"J. Nat. Prod."},{"key":"49939_CR57","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fct.2017.04.039","volume":"109","author":"MB Joray","year":"2017","unstructured":"Joray, M. B. et al. P53 tumor suppressor is required for efficient execution of the death program following treatment with a cytotoxic limonoid obtained from Melia azedarach. Food Chem. Toxicol. 109, 888\u2013897 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"49939_CR58","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acsmedchemlett.8b00324","volume":"9","author":"J Laiolo","year":"2018","unstructured":"Laiolo, J. et al. Analogues of the lignan pinoresinol as novel lead compounds for P-glycoprotein (P-gp) inhibitors. ACS Med. Chem. Lett. 9, 1186\u20131192 (2018).","journal-title":"ACS Med. Chem. Lett."},{"key":"49939_CR59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"49939_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jcc.540110404","volume":"11","author":"BH Besler","year":"1990","unstructured":"Besler, B. H., Merz, K. M. Jr. & Kollman, P. A. Atomic charges derived from semiempirical methods. J. Comput. Chem. 11, 431\u2013439 (1990).","journal-title":"J. Comput. Chem."},{"key":"49939_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cplett.2004.06.011","volume":"393","author":"T Yanai","year":"2004","unstructured":"Yanai, T., Tew, D. P. & Handy, N. C. A new hybrid exchange\u2013correlation functional using the Coulomb-attenuating method (CAM-B3LYP). Chem. Phys. Lett. 393, 51\u201357 (2004).","journal-title":"Chem. Phys. Lett."},{"key":"49939_CR62","doi-asserted-by":"crossref","unstructured":"Gaussian 16 Rev. C.01 (Wallingford, CT, 2016).","DOI":"10.5965\/1984723816322015001"},{"key":"49939_CR63","volume-title":"AMBER 2018","author":"D Case","year":"2018","unstructured":"Case, D. et al. AMBER 2018 (University of California, 2018)."},{"key":"49939_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph. Model. 25, 247\u2013260 (2006).","journal-title":"J. Mol. Graph. Model."},{"key":"49939_CR65","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1063\/1.439486","volume":"72","author":"HC Andersen","year":"1980","unstructured":"Andersen, H. C. Molecular dynamics simulations at constant pressure and\/or temperature. J. Chem. Phys. 72, 2384\u20132393 (1980).","journal-title":"J. Chem. Phys."},{"key":"49939_CR66","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"49939_CR67","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"49939_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. V. M. D. Visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"49939_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"49939_CR70","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49939-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T06:12:08Z","timestamp":1704175928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49939-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49939-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2883170\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}